Thermal hypersensitivity in a subset of irritable bowel syndrome patients

QiQi Zhou; Fillingim, Roger B.; Riley III, Joseph L.; Verne, G. Nicholas; Guslandi, Mario
July 2009
World Journal of Gastroenterology;7/14/2009, Vol. 15 Issue 26, p3254
Academic Journal
AIM: To characterize thermal hypersensitivity in patients with constipation- and diarrhea-predominant irritable bowel syndrome (IBS). METHODS: Thermal pain sensitivity was tested among patients with diarrhea-predominant IBS (D-IBS) and constipation-predominant IBS (C-IBS) compared to healthy subjects. A total of 42 patients (29 female and 13 male; mean age 27.0 ±6.4 years) with D-IBS; 24 patients (16 female and eight male; mean age 32.5 ±8.8 years) with C-IBS; and 52 control subjects (34 female and 18 male; mean age 27.3 ± 8.0 years) participated in the study. Thermal stimuli were delivered using a Medoc Thermal Sensory Analyzer with a 3 cm x 3 cm surface area. Heat pain threshold (HPTh) and heat pain tolerance (HPTo) were assessed on the left ventral forearm and left calf using an ascending method of limits. The Functional Bowel Disease Severity Index (FBDSI) was also obtained for all subjects. RESULTS: Controls were less sensitive than C-IBS and D-IBS (both at P < 0.001) with no differences between C-IBS and D-IBS for HPTh and HPTo. Thermal hyperalgesia was present in both groups of IBS patients relative to controls, with IBS patients reporting significantly lower pain threshold and pain tolerance at both test sites. Cluster analysis revealed the presence of subgroups of IBS patients based on thermal hyperalgesia. One cluster (17% of the sample) showed a profile of heat pain sensitivity very similar to that of healthy controls; a second cluster (47% of the sample) showed moderate heat pain sensitivity; and a third cluster (36% of the sample) showed a very high degree of thermal hyperalgesia. CONCLUSION: A subset of IBS patients had thermal hypersensitivity compared to controls, who reported significantly lower HPTh and HPTo. All IBS patients had a higher score on the FBDSI than controls. Interestingly, the subset of IBS patients with high thermal sensitivity (36%) had the highest FBDSI score compared to the other two groups of IBS patients.


Related Articles

  • Evaluation of health related quality of life in irritable bowel syndrome patients.  // Health & Quality of Life Outcomes;2012, Vol. 10 Issue 1, p12 

    The article presents a study examining the factors associated with quality of life (QOL) in Iranian irritable bowel syndrome patients (IBS). As mentioned, QOL was not different between IBS subtypes, and QOL was found to be inversely correlated with anxiety symptom. It is also mentioned that,...

  • Central processing of rectal pain in patients with irritable bowel syndrome: an fMRI study. Bonaz, B.; Baciu, M.; Papillon, E.; Bost, R.; Gueddah, N.; Le Bas, J.-F.; Fournet, J.; Segebarth, C. // American Journal of Gastroenterology;Mar2002, Vol. 97 Issue 3, p654 

    OBJECTIVES:In healthy subjects, the neural correlates of visceral pain bear much similarity with the correlates of somatic pain. In patients with irritable bowel syndrome, the central nervous system is believed to play a strong modulatory or etiological role in the pathophysiology of the...

  • Is there a difference between abdominal pain and discomfort in moderate to severe IBS patients? Sach, Joel; Bolus, Roger; Fitzgerald, Leah; Naliboff, Bruce D.; Chang, Lin; Mayer, Emeran A. // American Journal of Gastroenterology;Dec2002, Vol. 97 Issue 12, p3131 

    OBJECTIVES:The aims of this study were to: 1) determine the relative prevalence of self-reported pain-predominant and discomfort-predominant symptom patterns in irritable bowel syndrome (IBS) patients; and 2) test the hypotheses that pain-predominant patients report higher GI symptom severity,...

  • Bloating and Distension in Irritable Bowel Syndrome: The Role of Gastrointestinal Transit. Agrawal, Anurag; Houghton, Lesley A; Reilly, Brian; Morris, Julie; Whorwell, Peter J // American Journal of Gastroenterology;Aug2009, Vol. 104 Issue 8, p1998 

    OBJECTIVES:Patients with irritable bowel syndrome and constipation (IBS-C) show more abdominal distension than do those with diarrhea. Because constipation is often associated with delayed gastrointestinal transit, this study aimed at establishing whether patients with delayed transit show more...

  • Phase 3 Long-Term Safety Trial Results of Lubiprostone in Patients with Irritable Bowel Syndrome with Constipation was Recently Published in Alimentary Pharmacology and Therapeutics.  // Biomedical Market Newsletter;3/7/2012, Vol. 21, p1 

    The article focuses on a study designed to determine the effects of AMITIZA, drug in patients with Irritable Bowel Syndrome with Constipation (IBS-C) which revealed that long-term safety and tolerability profiles of drug can be achieved by long term administration of this drug. John F. Johanson,...

  • Case 25-2012. Cabot, Richard C.; Harris, Nancy Lee; Rosenberg, Eric S.; Shepard, Jo-Anne O.; Cort, Alice M.; Ebeling, Sally H.; McDonald, Emily K.; Zella, Garrett C.; Gee, Michael S.; Badizadegan, Kamran // New England Journal of Medicine;8/16/2012, Vol. 367 Issue 7, p659 

    The article describes the case of a 15-year-old boy who was admitted to the hospital because of recurrent abdominal pain and diarrhea. The boy also developed episodes of midline low back pain, which were worse in the morning and improved with activity and flexion. Details of the results of his...

  • Methylglyoxal Induces Systemic Symptoms of Irritable Bowel Syndrome. Zhang, Shuang; Jiao, Taiwei; Chen, Yushuai; Gao, Nan; Zhang, Lili; Jiang, Min // PLoS ONE;Aug2014, Vol. 9 Issue 8, p1 

    Patients with irritable bowel syndrome (IBS) show a wide range of symptoms including diarrhea, abdominal pain, changes in bowel habits, nausea, vomiting, headache, anxiety, depression and cognitive impairment. Methylglyoxal has been proved to be a potential toxic metabolite produced by...

  • Breakthrough in Intestinal Pain and Discomfort Management.  // Food Marketing & Technology;Apr2015, Vol. 29 Issue 2, p15 

    The article discusses the use of Saccharomyces cerevisiae CNCM I-3856, a probiotic yeast strain in improving abdominal pain and discomfort in people suffering from Irritable Bowel Syndrome (IBS) altering quality of life of people.

  • Exhibition explores relationship with pain.  // British Dental Journal;4/14/2012, Vol. 212 Issue 7, p312 

    The article previews the exhibition "Pain at the Dentist" to be held at the Alvarado Gallery in Hackney, London, England from April 20 to May 2, 2012.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics